|
|
|
1,001-5,000 employees
View all
|
|
Pharmaceuticals
|
|
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
|
|
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
We are committed to the relentless pursuit of science that can improve the lives of patients.
Our unique expertise in medicinal chemistry and biology has enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across Oncology and Inflammation & AutoImmunity.
Headquartered in Wilmington, Delaware, Incyte has more than 1,700 employees and operations in North America, Europe and Asia.
We are proud to have been recently recognized by Forbes as one of the World’s Most Innovative Companies. Additionally, Incyte has consecutively been named a Top Employer by Science Magazine, placing #2 on the 2020 list.
For more information about Incyte, please visit our corporate website at www.incyte.com and follow us on Twitter: www.twitter.com/incyte. See our Community Guidelines: http://bit.ly/2sV0H5W.
|
Incyte Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
74.47%
|
The widely used Incyte email format is {f}{last} (e.g. [email protected]) with 74.47% adoption across the company.
To contact Incyte customer service number in your country click here to find.
Herve Hoppenot is the CEO of Incyte. To contact Herve Hoppenot email at [email protected] or [email protected]. Or you may call 6099243903 or 6097602665
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.